Condition: Nasopharyngeal Carcinoma · Pathologic Complete Response · Tumor Microenvironment · Sponsor: Jiangxi Provincial Cancer Hospital
This study aims to explore the prognostic value of pathological remission after one cycle of induction chemotherapy in locally advanced nasopharyngeal carcinoma, and the change of immune micro-environment after one cycle induction chemotherapy, including the density of immune cells infiltration and tertiary lymphoid structures.
This description comes directly from the study's public registry record.
Jingao Li, PhD · 8613970866296 · lijingao@hotmail.com
Tianzhu Lu, PhD · lutianzhu2008@163.com
Always discuss trial participation with your own doctor first.
| Jingao Li | Nanchang, Jiangxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06182657